Regeneron released preliminary data of the DRCR.net Protocol T trial. The DRCR.net hasn‘t, and won’t for a while.

Necessity is the mother of invention: a problem needs solving, someone has a good idea, an invention is born. In clinical medicine, ideas often arise from the act of treating a patient

Sitting Down With… John Kanellopoulos Clinical Professor of Ophthalmology, New York University Medical School, Partner at OMMA Eye Institute, and Founder and Scientific Manager of Laservision.gr Institute, Athens, Greece

Maurice Saatchi wants new legislation to free British doctors from fear of litigation in the pursuit of innovation. Others view it as a charlatan’s charter

Showcasing the greatest ophthalmic advances of the year

Alimera and Allergan benefit from new FDA approvals, Allergan continues to battle Valeant, and Oculentis sues Lenstec over IOL patent infringement

The world’s top clinicians and captains of industry came together in London last month to discuss the future of ophthalmology. Here’s what we learned

What does analysis of the last five years of the literature on vitreomacular traction/ adhesion tell us about the priorities of the field and the major contributors to it?

Sitting Down With… Charles McGhee, Director of the New Zealand National Eye Centre, University of Auckland, New Zealand.

Mark Latina recounts his story of the invention of selective laser trabeculoplasty (SLT).